Impact of smoking on disease severity and treatment outcomes in hidradenitis suppurativa

Documenti analoghi

• Prevalence of risk factors affecting the use of oral JAK inhibitors in hidradenitis suppurativa
  di: Ditte Georgina Zhang, et al.
  Pubblicazione: (2025)
• Botulinum toxin type A efficacy on pain and suppuration in hidradenitis suppurativa
  di: Noor F. Goandal, et al.
  Pubblicazione: (2025)
• Early response patterns on omalizumab predict long‐term outcomes in chronic spontaneous urticaria
  di: Ditte Georgina Zhang, et al.
  Pubblicazione: (2025)
• First steps into AI‐supported hidradenitis suppurativa severity assessment
  di: Thrasyvoulos Tzellos
  Pubblicazione: (2024)
• Topical corticosteroids in the era of new topical therapies: Balancing efficacy and safety for long‐term use
  di: Alexander Egeberg, et al.
  Pubblicazione: (2024)